Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of <scp>CALGB</scp> (Alliance) 10301, a multicentre phase <scp>II</scp> study
Distribution of the number of citations over years.